Pulmonx Corporation (LUNG)
After hours:
| Previous Close | 9.28 |
| Open | 9.29 |
| Bid | 9.52 x 200 |
| Ask | 9.56 x 500 |
| Day's Range | 9.29 - 9.74 |
| 52 Week Range | 7.11 - 14.84 |
| Volume | |
| Avg. Volume | 629,498 |
| Market Cap | 369.915M |
| Beta (5Y Monthly) | 0.60 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.54 |
| Earnings Date | Jul 31, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.40 |
GlobeNewswirePulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that the Compensation Committee of the Board of Directors of Pulmonx (the “Compensation Committee”) granted inducement awards consisting of a non-statutory stock option to purchase 241,409 shares of common stock and a time-based restricted stock unit award for 125,870 shares of common stock on Ma
ZacksWall Street Analysts See a 56.11% Upside in Pulmonx (LUNG): Can the Stock Really Move This High?
The consensus price target hints at a 56.1% upside potential for Pulmonx (LUNG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Simply Wall St.Earnings Update: Pulmonx Corporation (NASDAQ:LUNG) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
Pulmonx Corporation ( NASDAQ:LUNG ) investors will be delighted, with the company turning in some strong numbers with...
